Mr. Alpha Diallo is a New York, New York based nurse practitioner. Active license number of Mr. Alpha Diallo is 343331 for Family in New York. His current practice location is 1275 York Ave, New York. Patients can reach him at 917-370-0745. Mr. Alpha Diallo is NP and his NPI number (Unique professional ID assigned by NPPES) is 1093293185. Mr. Alpha Diallo has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Mr. Alpha Diallo speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1093293185
NPI Enumeration Date:
01 Aug, 2018
NPI Last Update On:
01 Aug, 2018
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Alpha Diallo are as mentioned below.
License Number
Specialization
State
Status
343331
Family
New York
Primary
686891
Registered Nurse
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mr. Alpha Diallo 1468 Madison Ave, New York, New York
Zip:
10029-6508
Phone Number:
917-370-0745
Patients can reach Mr. Alpha Diallo at 1275 York Ave, New York, New York or can call to book an appointment on 917-370-0745.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 January, 2025.